1-15 of 15
Federica Loscocco
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Disease Course and Treatment Patterns of Acute Myeloid Leukemia with FLT3 Mutations and Myeloid Sarcoma Reveal High Efficacy of Gilteritinib: A Multicentric Retrospective Study

Francesco Angotzi, Erika Borlenghi, Chiara Sartor, Maria Benedetta Giannini, Giovanni Marconi, Edoardo Tamellini, Mauro Turrini, Federica Loscocco, Ernesta Audisio, Vincenzo Federico, Calogero Vetro, Andrea Visentin, Carmela Gurrieri, Livio Trentin, Felicetto Ferrara, Federica Lessi
Journal: Blood
Blood (2024) 144 (Supplement 1): 1523.
https://doi.org/10.1182/blood-2024-209605
Published: 2024
Journal Articles

Comparative Effectiveness of High-Dose Bendamustine-EAM Versus BEAM in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

Erica Tsang, Diego Villa, MD, Federica Loscocco, Alina S Gerrie, MD, Giuseppe Visani, Maryse Power, MB, Barbara Guiducci, Cristina Clissa, MD PhD, Joseph M Connors, MD, Kerry J Savage, BSc, MD MSc, Kevin W Song, MD, Cindy Toze, Yasser Abou-Mourad, Heather Sutherland, MD, David Sanford, MD, Stephen H Nantel, MD, Laurie H. Sehn, MDMPH, David W. Scott, MD PhD FRACP, FRCPA, Alessandro Isidori, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3291.
https://doi.org/10.1182/blood.V130.Suppl_1.3291.3291
Published: 2017
Journal Articles

Deferasirox Boosts Hematopoietic Recovery after ALLO-Sct

Giuseppe Visani, Claudio Giardini, Federica Loscocco, Barbara Guiducci, Cristina Clissa, MD PhD, Elisa Gabucci, Alessandro Isidori, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5463.
https://doi.org/10.1182/blood.V130.Suppl_1.5463.5463
Published: 2017
Journal Articles

The hOCT1 and ABCB1 Polymorphisms Don't Condition the Efficacy and Toxicity of Nilotinib As First-Line Treatment: An Italian Multicentric Experience

Sara Galimberti, MD PhD, Cristina Bucelli, MD, Elena Arrigoni, PhD, Claudia Baratè, Susanna Grassi, Federica Ricci, MD, Francesca Guerrini, PhD, Elena Ciabatti, PhD, Carmen Fava, MD, Antonio D'Avolio, Giulia Fontanelli, MD, Giovanna Rege Cambrin, MD, Alessandro Isidori, MD PhD, Federica Loscocco, PhD, Giovanni Caocci, MD, Marianna Greco, PhD, Monica Bocchia, MD, Lara Aprile, MD, Antonella Gozzini, MD, Barbara Scappini, MD, Daniele Cattaneo, MD, Giorgio La Nasa, MD, Alberto Bosi, MD, Mario Petrini, MD PhD, Pietro Leoni, MD, Romano Danesi, MD PhD, Giuseppe Saglio, MD PhD, Giuseppe Visani, MD, Agostino Cortellezzi, MD, Anna Rita Scortechini, MD, Alessandra Iurlo, MD, Antonello Di Paolo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3951.
https://doi.org/10.1182/blood.V128.22.3951.3951
Published: 2016
Journal Articles

Benda-BEAM High-Dose Therapy Prior to Auto-SCT Is Effective in Resistant/Relapsed DLBCL

Alessandro Isidori, MD PhD, Stefano Guidi, Potito Rosario Scalzulli, MD, Attilio Olivieri, MD, Emanuele Angelucci, Saveria Capria, MD, Francesca Patriarca, Barbara Castagnari, MD, Francesco Angrilli, MD, Daniele Vallisa, MD, Gerardo Musuraca, Andrea Mengarelli, MD, Piero Galieni, Gaudio Francesco, Patrizia Tosi, Pier Luigi Zinzani, MD PhD, Alberto Bosi, Donatella Baronciani, Nicola Cascavilla, MD, Barbara Guiducci, Cristina Clissa, MD, Elisa Gabucci, Marco Rocchi, Federica Loscocco, PhD, Giuseppe Visani, MD
Journal: Blood
Blood (2015) 126 (23): 1999.
https://doi.org/10.1182/blood.V126.23.1999.1999
Published: 2015
Journal Articles

Environmental Nanoparticles Are Significantly over-Expressed in Acute Myeloid Leukemia: a Novel Pathogenetic Cofactor?

Giuseppe Visani, MD, Anita Manti, Laura Valentini, Barbara Canonico, Federica Loscocco, PhD, Alessandro Isidori, MD PhD, Elisa Gabucci, Pietro Gobbi, Stefano Montanari, Marco Rocchi, Stefano Papa, Maria Antonietta Gatti, MD
Journal: Blood
Blood (2015) 126 (23): 4965.
https://doi.org/10.1182/blood.V126.23.4965.4965
Published: 2015
Journal Articles

Tosedostat Plus Low Dose Cytarabine Induces a High Rate of Responses That Can be Predicted By Genetic Profiling in Elderly AML

Giuseppe Visani, MD, Federica Loscocco, PhD, Fabio Fuligni, Eliana Zuffa, MD, Alberto Sensi, MD, Alfonso Zaccaria, MD, Gerardo Musuraca, MD, Barbara Giannini, Alessandro Lucchesi, Francesca Fabbri, Anna Maria Mianulli, Patrizia Tosi, MD, Michela Tonelli, Anna Candoni, MD, Renato Fanin, Giovanni Sparaventi, Marco Gobbi, MD, Marino Clavio, Marco Rocchi, Pier Paolo Piccaluga, MD PhD, Alessandro Isidori, MD PhD
Journal: Blood
Blood (2015) 126 (23): 329.
https://doi.org/10.1182/blood.V126.23.329.329
Published: 2015
Journal Articles

Prognostic Impact of TS, MTHFR and XRCC1 Genetic Variants in 113 Patients with Myelodysplastic Syndromes

Federica Loscocco, PhD, Giuseppe Visani, MD, Elisa Giacomini, Annamaria Ruzzo, Sara Galimberti, MD, Maria Teresa Voso, MD PhD, Carlo Finelli, MD, Elena Ciabatti, Emiliano Fabiani, Francesco Graziano, Sara Barulli, Antonio Volpe, MD, Domenico Magro, Pier Paolo Piccaluga, MD PhD, Fabio Fuligni, Marco Vignetti, Paola Fazi, Alfonso Piciocchi, Cristina Clissa, MD, Elisa Gabucci, Marco Rocchi, Mauro Magnani, Alessandro Isidori, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1675.
https://doi.org/10.1182/blood.V126.23.1675.1675
Published: 2015
Journal Articles

Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma

Clinical Trials & Observations
Giuseppe Visani, Pietro Maria Stefani, Saveria Capria, Lara Malerba, Piero Galieni, Francesco Gaudio, Giorgina Specchia, Giovanna Meloni, Filippo Gherlinzoni, Roberta Gonella, Marco Gobbi, Armando Santoro, Felicetto Ferrara, Marco Rocchi, Enrique M. Ocio, Maria Dolores Caballero, Federica Loscocco, Alessandro Isidori
Journal: Blood
Blood (2014) 124 (19): 3029–3031.
https://doi.org/10.1182/blood-2014-08-596668
Published: 2014
Journal Articles

The Mutational Status Of Genes Involved In DNA Repair and Folate Pathway Predicts Overall Survival Of Patients With Low-Risk, Untreated Myelodysplastic Syndrome

Alessandro Isidori, MD, PhD, Annamaria Ruzzo, PhD, Federica Loscocco, Maria Teresa Voso, M.D., Francesco Graziano, Sara Barulli, Emanuele Canestrari, Antonio Volpe, MD, Domenico Magro, MD, Pier Paolo Piccaluga, MD, PhD, Fabio Fuligni, Stefania Paolini, Teresa Ricciardi, Paola Picardi, Elisa Giacomini, Marco Rocchi, Mauro Magnani, Giuseppe Visani, MD
Journal: Blood
Blood (2013) 122 (21): 2815.
https://doi.org/10.1182/blood.V122.21.2815.2815
Published: 2013
Journal Articles

Bendamustine, Etoposide, Cytarabine and Melphalan (BeEAM) Followed By Autologous Stem Cell Transplantation Produce a 3-Year Progression-Free Survival Of 75% In Heavily Pre-Treated Hodgkin and Non-Hodgkin Lymphoma

Giuseppe Visani, MD, Pietro Maria Stefani, Saveria Capria, MD, Lara Malerba, Piero Galieni, MD, Francesco Gaudio, Giorgina Specchia, MD, Giovanna Meloni, Filippo Gherlinzoni, MD, Claudio Giardini, MD, Sadia Falcioni, Roberta Gonella, Francesca Cuberli, Marco Gobbi, MD, Barbara Sarina, MD, Armando Santoro, MD, Felicetto Ferrara, Marco Rocchi, Enrique M. Ocio, Maria Dolores Caballero, Paola Picardi, Teresa Ricciardi, Federica Loscocco, Alessandro Isidori, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2134.
https://doi.org/10.1182/blood.V122.21.2134.2134
Published: 2013
Journal Articles

Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients

Giuseppe Visani, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Federica Loscocco, Pier Paolo Piccaluga, Fabio Fuligni, Anna Gazzola, PhD, Maura Rossi, Antonella Laginestra, Maria Rita Caraci, Cira Riccardi, Axel Visani, Sara Barulli, Barbara Guiducci, Teresa Ricciardi, Giovanni Sparaventi, Marco Rocchi, Alessandro Isidori, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 496.
https://doi.org/10.1182/blood.V122.21.496.496
Published: 2013
Journal Articles

LOW-DOSE LENALIDOMIDE COUPLED with LOW-DOSE Cytarabine INDUCES COMPLETE REMISSION of Elderly ACUTE Myeloid LEUKEMIA PATIENTS with Unfavorable Citogenetics: PRELIMINARY RESULTS of A PHASE II STUDY,

Giuseppe Visani, Felicetto Ferrara, MD, Francesco Di Raimondo, MD, Maria Rita Caraci, Tiziana Izzo, Sara Barulli, Barbara Guiducci, Federica Loscocco, Teresa Ricciardi, Giovanni Sparaventi, Alessandro Isidori, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3627.
https://doi.org/10.1182/blood.V118.21.3627.3627
Published: 2011
Journal Articles

A Novel High Dose Chemotherapy Strategy with Bendamustine In Adjunct to Etoposide, Cytarabine and Melphalan (BeEAM) Followed by Autologous Stem Cell Rescue Is Safe and Highly Effective for the Treatment of Resistant/Relapsed Lymphoma Patients: a Phase I-II Study on 44 Patients

Giuseppe Visani, Lara Malerba, Pietro Maria Stefani, Saveria Capria, Piero Galieni, Francesco Gaudio, Giorgina Specchia, Giovanna Meloni, MD, Filippo Gherlinzoni, MD, Claudio Giardini, Sadia Falcioni, Federica Loscocco, Francesca Cuberli, Marco Gobbi, MD, Armando Santoro, Barbara Sarina, Marco Rocchi, Alessandro Isidori, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 31.
https://doi.org/10.1182/blood.V116.21.31.31
Published: 2010
Journal Articles

The Dose and the duration of frontline therapy with Imatinib does not affect response to Dasatinib in Imatinib-Resistant or -intolerant patients with chronic myeloid leukemia (CML). Results from a real Life-Based Italian Multicenter retrospective study on 124 Patients.

Giuseppe Visani, Massimo Breccia, Pier Paolo Piccaluga, Antonella Gozzini, Giorgina Specchia, Enrico Montefusco, Enrica Morra, MD, Mario Annunziata, Luigiana Luciano, Andrea Camera, MD, Francesco Cavazzini, MD, Fabio Stagno, Francesco Di Raimondo, M.D., Patrizia Pregno, Francesca Pirillo, Valeria Santini, MD, Alberto Bosi, MD, Matteo Pacilli, MD, Ester Pungolino, Emilio Usala, MD, Emanuele Angelucci, MD, Monica Crugnola, Gianni Binotto, Elena Maino, Federica Loscocco, Sara Barulli, Giuseppina Nicolini, Antonio Cuneo, Roberto Latagliata, MD, Felicetto Ferrara, Alessandro Isidori, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1124.
https://doi.org/10.1182/blood.V114.22.1124.1124
Published: 2009